- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/4162 - 1,2-Diazoles condensed with heterocyclic ring systems
Patent holdings for IPC class A61K 31/4162
Total number of patents in this class: 1103
10-year publication summary
|
65
|
53
|
64
|
84
|
77
|
76
|
90
|
95
|
74
|
29
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Novartis AG | 11238 |
37 |
| Merck Sharp & Dohme LLC | 3689 |
28 |
| Achillion Pharmaceuticals, Inc. | 176 |
26 |
| Bayer AG | 3045 |
20 |
| Boehringer Ingelheim International GmbH | 4629 |
17 |
| Nerviano Medical Sciences S.r.l. | 256 |
16 |
| F. Hoffmann-La Roche AG | 7958 |
15 |
| Merck Sharp & Dohme Corp. | 2247 |
15 |
| The Broad Institute, Inc. | 1584 |
15 |
| Bayer Pharma AG | 1096 |
14 |
| Vertex Pharmaceuticals Incorporated | 1581 |
14 |
| Janssen Pharmaceutica N.V. | 3839 |
13 |
| Warsaw Orthopedic, Inc. | 3184 |
13 |
| Dana-Farber Cancer Institute, Inc. | 2455 |
13 |
| Array BioPharma Inc. | 551 |
12 |
| Takeda Pharmaceutical Company Limited | 2961 |
10 |
| Merck Patent GmbH | 5909 |
9 |
| The Regents of the University of Colorado, a body corporate | 2430 |
9 |
| Bristol-myers Squibb Company | 5080 |
8 |
| Pfizer Inc. | 3322 |
8 |
| Other owners | 791 |